These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25997365)

  • 21. New treatment options for onychomycosis.
    Mordon SR; Betrouni N; Trelles MA; Leclère FM
    J Cosmet Laser Ther; 2014 Dec; 16(6):306-10. PubMed ID: 25148411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onychomycosis: rationalization of topical treatment.
    Shemer A; Trau H; Davidovici B; Amichai B; Grunwald MH
    Isr Med Assoc J; 2008 Jun; 10(6):415-6. PubMed ID: 18669135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal therapy for onychomycosis in children.
    Feldstein S; Totri C; Friedlander SF
    Clin Dermatol; 2015; 33(3):333-9. PubMed ID: 25889135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical and surgical treatment of onychomycosis.
    Cohen PR; Scher RK
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S74-7. PubMed ID: 8077513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical and physical strategies in onychomycosis topical treatment: A review.
    Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
    Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in therapies for onychomycosis and its management.
    Gupta AK; Stec N
    F1000Res; 2019; 8():. PubMed ID: 31297182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onychomycosis: therapeutic update.
    Scher RK
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S21-6. PubMed ID: 10367912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the management of onychomycosis.
    Piraccini BM; Gianni C
    G Ital Dermatol Venereol; 2013 Dec; 148(6):633-8. PubMed ID: 24442043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How I treat... onychomycosis by topical therapy].
    Piérard GE; Piérard-Franchimont C
    Rev Med Liege; 2015 Jan; 70(1):5-11. PubMed ID: 25902599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onychomycosis: Treatment and prevention of recurrence.
    Lipner SR; Scher RK
    J Am Acad Dermatol; 2019 Apr; 80(4):853-867. PubMed ID: 29959962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tavaborole for the treatment of onychomycosis.
    Elewski BE; Tosti A
    Expert Opin Pharmacother; 2014 Jul; 15(10):1439-48. PubMed ID: 24856836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?].
    Ginter G; Rieger E; Heigl K; Propst E
    Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in topical and systemic antifungals.
    Zhang AY; Camp WL; Elewski BE
    Dermatol Clin; 2007 Apr; 25(2):165-83, vi. PubMed ID: 17430754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment and management strategies of onychomycosis.
    Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
    J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onychomycosis: Current trends in diagnosis and treatment.
    Westerberg DP; Voyack MJ
    Am Fam Physician; 2013 Dec; 88(11):762-70. PubMed ID: 24364524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for biofilms in onychomycosis.
    Gupta AK; Foley KA
    G Ital Dermatol Venereol; 2019 Feb; 154(1):50-55. PubMed ID: 29683287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of onychomycosis therapy may involve a combination of approaches.
    Hay RJ
    Br J Dermatol; 2001 Oct; 145 Suppl 60():3-8. PubMed ID: 11777262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.